Patients that will undergo lung cancer surgery, chemotherapy, radiation therapy and chemoradiation therapy
Conditions
Sponsors
St. Marianna University School of Medicine Division of Respiratory and Infectious Diseases, Department of Internal Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) patients 20 years of age or over with lung cancer. 2) Agree to give informed consent
Exclusion criteria
Exclusion criteria: 1) Refuse to give informed consent 2) Patients who are pregnant, possibly pregnant, or lactating. 3) Patients with renal failure. (serum creatinine > 2.0 mg/dL, BUN > 30mg/dl) 4) AST or ALT > 100IU 5) Patients with severe diabetes, hyperlipidemia or hyperuricemia 6) Patients who are judged inappropriate by the doctor in charge.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To observe if VOC peaks specific to lung cancer show changes after treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate VOC peak changes for different treatments; chemotherapy, radiation therapy and chemoradiation therapy. To measure VOC peaks for the affected and healthy side of the lungs during single-sided ventilation. | — |
Countries
Japan
Contacts
Public ContactMariko Okamoto
St. Marianna University School of Medicine Division of Respiratory and Infectious Diseases, Department of Internal Medicine
Outcome results
None listed